EFFECT OF FAMOTIDINE ON THEOPHYLLINE PHARMACOKINETICS IN THE RAT

[1] CARPENTER P, 1985, ADOLESCENCE, V20, P599

[2] CHERMOS AN, 1986, CLIN PHARMACOL THER, V39, P187

[3] GARG D C, 1982, Clinical Pharmacology and Therapeutics, V31, P228

[4] FAMOTIDINE - A NOTABLE LACK OF DRUG-INTERACTIONS [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 : 55 - 60

[5] FAMOTIDINE, A NEW H2-RECEPTOR ANTAGONIST, DOES NOT AFFECT HEPATIC ELIMINATION OF DIAZEPAM OR TUBULAR SECRETION OF PROCAINAMIDE [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (06) : 671 - 675

[6] KNODELL RG, 1982, GASTROENTEROLOGY, V82, P84

[7] RECENT ADVANCES IN PHARMACEUTICAL CHEMISTRY .2. HISTAMINE H-2-RECEPTOR ANTAGONISTS [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1986, 11 (06): : 389 - 408

[8] INTERACTION OF DIAZEPAM WITH FAMOTIDINE AND CIMETIDINE, 2 H-2-RECEPTOR ANTAGONISTS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (04) : 299 - 303

[9] POWELL JR, 1984, AM J MED, V77, P57

[10] RENDIC S, 1983, DRUG METAB DISPOS, V11, P137

[1] CARPENTER P, 1985, ADOLESCENCE, V20, P599

[2] CHERMOS AN, 1986, CLIN PHARMACOL THER, V39, P187

[3] GARG D C, 1982, Clinical Pharmacology and Therapeutics, V31, P228

[4] FAMOTIDINE - A NOTABLE LACK OF DRUG-INTERACTIONS [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 : 55 - 60

[5] FAMOTIDINE, A NEW H2-RECEPTOR ANTAGONIST, DOES NOT AFFECT HEPATIC ELIMINATION OF DIAZEPAM OR TUBULAR SECRETION OF PROCAINAMIDE [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (06) : 671 - 675

[6] KNODELL RG, 1982, GASTROENTEROLOGY, V82, P84

[7] RECENT ADVANCES IN PHARMACEUTICAL CHEMISTRY .2. HISTAMINE H-2-RECEPTOR ANTAGONISTS [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1986, 11 (06): : 389 - 408

[8] INTERACTION OF DIAZEPAM WITH FAMOTIDINE AND CIMETIDINE, 2 H-2-RECEPTOR ANTAGONISTS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (04) : 299 - 303

[9] POWELL JR, 1984, AM J MED, V77, P57

[10] RENDIC S, 1983, DRUG METAB DISPOS, V11, P137